1277552

Lawrence Ginsberg, M.D. — FEI 3038167427

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance